Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Mitotaneis a medication used to treat specific types of cancer and adrenal gland-related disorders.What is the recommended dosage of Mitotane?The clinically recommended dose of Mit···【more】
Article source：Captain MedicineRelease date：2024-08-19Recommended：370
Selpercatinib blocks tumor growth and spread by inhibiting the kinase activity of the RET fusion protein. As a targeted drug, it has been used to treat a variety of cancer types as···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：273
Selpercatinib is an innovative RET inhibitor specifically designed to treat cancers associated with RET gene mutations. By interfering with the signaling pathways of cancer cells, ···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：317
Selpercatinib is a highly selective RET inhibitor that inhibits the growth of tumor cells by blocking RET kinase activity. In May 2020, the FDA approved the drug for use as an impo···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：258
Selpercatinib is the first targeted drug specifically targeting RET gene mutations and was approved by the FDA in 2020; By inhibiting the activity of RET kinase and blocking the gr···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：228
In May 2020, Selpercatinib was approved by the FDA for the treatment of various cancers caused by RET gene mutations. The drug stops the spread of the lesion by interfering with th···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：301
Selpercatinib treats cancer patients by specifically inhibiting RET kinase activity. In 2020, it was approved for marketing in United States, becoming the first drug specifically t···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：255
Selpercatinib helps control the proliferation and metastasis of cancer cells by blocking the RET signaling pathway. The drug, which is indicated for patients over 12 years of age, ···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：336
As a highly selective RET inhibitor, Selpercatinib is used for the treatment of RET fusion-positive and mutation-associated cancers. It was approved by the FDA in 2020 and has show···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：264
The commonly used dosage form of Mitotane is a tablet, which is an antineoplastic drug. It is used to treat inoperable adrenocortical tumors. Cushing syndrome can also be treated.W···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：262
Selpercatinib is a targeted drug that specifically targets mutations in the RET gene. By inhibiting RET kinase activity, it prevents the growth and spread of cancer cells. It is su···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：260
By inhibiting the synthesis of adrenocortical hormones, Mitotane slows or stops the growth of tumor cells and improves related symptoms to some extent.What diseases is Mitotan suit···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：301
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：2272025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：4532024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：2332025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：2462025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：2262025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：2552025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：2352025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：2172025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
